Updated Jul 16, 2026
Holtham Angela has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Angela Holtham serves as a director of Oncolytics Biotech Inc., as disclosed in the company’s SEC filings around 2026-06-03. The available SEC context confirms her role as a director but does not provide additional publicly verifiable biographical details within this context.
| Role | Director |
|---|---|
| Notability | 20/100 |
Angela Holtham serves as a director of Oncolytics Biotech Inc., as disclosed in the company’s SEC filings around 2026-06-03. The available SEC context confirms her role as a director but does not provide additional publicly verifiable biographical details within this context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Holtham Angela profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.